ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
According to ASP Isotopes Inc. Common Stock's latest financial reports the company's current earnings (TTM) are $-16,300,259. The earnings displayed on this page is the company's Pretax Income.
Year | Income Before Tax | Net Income |
---|---|---|
2023 | $-16,300,259 | $-16,286,234 |
2022 | $-4,945,139 | $-4,791,230 |
2021 | $-2,607,927 | $-2,607,927 |
2019 | $-10,360,000 | $-10,256,000 |